

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.47471282 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.47471282 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.45676189 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.21567004 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.60451910 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 5.57439578 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.56852198 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.17019265 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 5.01420265 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 5.01420265 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.01420265 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.01420265 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.01420265 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 5.01420265 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.00786792 |
| 16 | leukocyte aggregation (GO:0070486) | 4.97527183 |
| 17 | detection of other organism (GO:0098543) | 4.96750514 |
| 18 | detection of bacterium (GO:0016045) | 4.92575353 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 4.58748083 |
| 20 | response to peptidoglycan (GO:0032494) | 4.57089243 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.55962297 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.52702241 |
| 23 | cellular extravasation (GO:0045123) | 4.33990251 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.28607040 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.28164803 |
| 26 | negative thymic T cell selection (GO:0045060) | 4.19408789 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 4.19021003 |
| 28 | neutrophil activation (GO:0042119) | 4.18711745 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 4.10367868 |
| 30 | negative T cell selection (GO:0043383) | 4.09074912 |
| 31 | positive thymic T cell selection (GO:0045059) | 4.02023221 |
| 32 | regulation of B cell differentiation (GO:0045577) | 4.01214878 |
| 33 | response to interleukin-15 (GO:0070672) | 3.97457935 |
| 34 | activated T cell proliferation (GO:0050798) | 3.96627586 |
| 35 | negative regulation of T cell mediated immunity (GO:0002710) | 3.96107962 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.90827612 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.88069239 |
| 38 | B cell receptor signaling pathway (GO:0050853) | 3.85776454 |
| 39 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.85154127 |
| 40 | negative regulation of interleukin-12 production (GO:0032695) | 3.83475350 |
| 41 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.80523011 |
| 42 | immunoglobulin mediated immune response (GO:0016064) | 3.76897358 |
| 43 | positive regulation of granulocyte differentiation (GO:0030854) | 3.74753589 |
| 44 | granulocyte activation (GO:0036230) | 3.73809349 |
| 45 | positive regulation of mast cell activation (GO:0033005) | 3.67816471 |
| 46 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.64422502 |
| 47 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.60325090 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 3.59933039 |
| 49 | response to host immune response (GO:0052572) | 3.59398234 |
| 50 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.59398234 |
| 51 | respiratory burst (GO:0045730) | 3.59159151 |
| 52 | response to muramyl dipeptide (GO:0032495) | 3.58961198 |
| 53 | negative regulation of phagocytosis (GO:0050765) | 3.57098189 |
| 54 | microglial cell activation (GO:0001774) | 3.55940080 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 3.51407927 |
| 56 | cellular response to interleukin-15 (GO:0071350) | 3.50918523 |
| 57 | positive T cell selection (GO:0043368) | 3.50756341 |
| 58 | T cell selection (GO:0045058) | 3.50358429 |
| 59 | T cell migration (GO:0072678) | 3.49154229 |
| 60 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.48791905 |
| 61 | leukocyte degranulation (GO:0043299) | 3.40910018 |
| 62 | detection of biotic stimulus (GO:0009595) | 3.40879835 |
| 63 | regulation of tolerance induction (GO:0002643) | 3.39831827 |
| 64 | regulation of mast cell activation (GO:0033003) | 3.38203993 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.35803378 |
| 66 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.35634327 |
| 67 | regulation of T cell tolerance induction (GO:0002664) | 3.35477158 |
| 68 | thymic T cell selection (GO:0045061) | 3.32230195 |
| 69 | response to host (GO:0075136) | 3.30841749 |
| 70 | response to host defenses (GO:0052200) | 3.30841749 |
| 71 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.30841749 |
| 72 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.28855767 |
| 73 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.24059280 |
| 74 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.19308047 |
| 75 | neutrophil mediated immunity (GO:0002446) | 3.18841888 |
| 76 | tolerance induction (GO:0002507) | 3.14592423 |
| 77 | detection of molecule of bacterial origin (GO:0032490) | 3.13278364 |
| 78 | positive regulation of mast cell degranulation (GO:0043306) | 3.11796154 |
| 79 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.11796154 |
| 80 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.10911560 |
| 81 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.10911560 |
| 82 | macrophage activation (GO:0042116) | 3.10727731 |
| 83 | defense response to protozoan (GO:0042832) | 3.08384455 |
| 84 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.04839172 |
| 85 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.04275307 |
| 86 | B cell mediated immunity (GO:0019724) | 3.03428773 |
| 87 | negative regulation of innate immune response (GO:0045824) | 3.02952337 |
| 88 | regulation of regulated secretory pathway (GO:1903305) | 3.00724660 |
| 89 | cellular response to type I interferon (GO:0071357) | 3.00312506 |
| 90 | type I interferon signaling pathway (GO:0060337) | 3.00312506 |
| 91 | response to type I interferon (GO:0034340) | 3.00154395 |
| 92 | megakaryocyte development (GO:0035855) | 2.98454696 |
| 93 | regulation of granulocyte differentiation (GO:0030852) | 2.96451185 |
| 94 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.93111938 |
| 95 | germinal center formation (GO:0002467) | 2.92553151 |
| 96 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.92153417 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.92153417 |
| 98 | negative regulation of interleukin-6 production (GO:0032715) | 2.90794527 |
| 99 | positive regulation of tolerance induction (GO:0002645) | 2.90716010 |
| 100 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.89028371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.49726104 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.09713521 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.05947122 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.92518010 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.66510625 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.49686268 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.24768790 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.12558473 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.07751518 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.98403968 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.87170742 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.84207700 |
| 13 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.78526431 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.71664043 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.70471795 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.69378707 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.68742534 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.66312624 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.65965893 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65413462 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.58073436 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.56486344 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.52156219 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.48760358 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 2.46105641 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.44485442 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.42976329 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.33680693 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 2.33191602 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.29200905 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.19850008 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.17274273 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.15119910 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13435560 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.96277856 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96226828 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.94894740 |
| 38 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.87127005 |
| 39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.85941288 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85644146 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.84843937 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80430628 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.78328823 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.77788252 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.75519939 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.75369698 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.74095782 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.69647171 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60104695 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59412064 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58390130 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.57964531 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.52586837 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.52053051 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50626002 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49254552 |
| 57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48487706 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47276366 |
| 59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.43536443 |
| 60 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43160967 |
| 61 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40906669 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40109581 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38073118 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.37307905 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33037789 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32880345 |
| 67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.30681994 |
| 68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30670239 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28589321 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28045295 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.27059636 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26550963 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22936043 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22418304 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19556892 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18388888 |
| 77 | GATA2_19941826_ChIP-Seq_K562_Human | 1.18352740 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17789285 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15513422 |
| 80 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.14153191 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12589880 |
| 82 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12342087 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11092285 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10733043 |
| 85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09278493 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08986852 |
| 87 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.08506222 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08009129 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07718768 |
| 90 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06507084 |
| 91 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05717204 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03428846 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01874176 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97269909 |
| 95 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97236914 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91866074 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91208067 |
| 98 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89198889 |
| 99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88928739 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84331984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.37253854 |
| 2 | MP0003436_decreased_susceptibility_to | 4.09704743 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.87202570 |
| 4 | MP0003303_peritoneal_inflammation | 3.42951541 |
| 5 | MP0005671_abnormal_response_to | 3.14752191 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.05371712 |
| 7 | MP0001800_abnormal_humoral_immune | 3.04482512 |
| 8 | MP0002419_abnormal_innate_immunity | 3.02213708 |
| 9 | MP0005464_abnormal_platelet_physiology | 2.94635847 |
| 10 | MP0005025_abnormal_response_to | 2.84756325 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.84099748 |
| 12 | MP0005387_immune_system_phenotype | 2.70152322 |
| 13 | MP0001790_abnormal_immune_system | 2.70152322 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.66514717 |
| 15 | MP0002723_abnormal_immune_serum | 2.64841746 |
| 16 | MP0001819_abnormal_immune_cell | 2.63369681 |
| 17 | MP0000685_abnormal_immune_system | 2.59406007 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.55440290 |
| 19 | MP0006082_CNS_inflammation | 2.52465724 |
| 20 | MP0009785_altered_susceptibility_to | 2.45653880 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.42208137 |
| 22 | MP0002398_abnormal_bone_marrow | 2.30178215 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.26864636 |
| 24 | MP0002405_respiratory_system_inflammati | 2.15728567 |
| 25 | MP0000716_abnormal_immune_system | 2.08590294 |
| 26 | MP0000465_gastrointestinal_hemorrhage | 2.07349380 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.07234300 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.96185788 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.94528497 |
| 30 | MP0009278_abnormal_bone_marrow | 1.94210622 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.92920915 |
| 32 | MP0002132_abnormal_respiratory_system | 1.91818007 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.91069872 |
| 34 | MP0002722_abnormal_immune_system | 1.88255114 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.83191961 |
| 36 | MP0003828_pulmonary_edema | 1.82646755 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.79999026 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.79775093 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.74283762 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.74283762 |
| 41 | MP0002429_abnormal_blood_cell | 1.71773032 |
| 42 | MP0008260_abnormal_autophagy | 1.71628850 |
| 43 | MP0003866_abnormal_defecation | 1.67744651 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.67089350 |
| 45 | MP0004947_skin_inflammation | 1.63351790 |
| 46 | MP0001851_eye_inflammation | 1.59281913 |
| 47 | MP0008469_abnormal_protein_level | 1.37415922 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.36659187 |
| 49 | MP0004381_abnormal_hair_follicle | 1.29295882 |
| 50 | MP0002166_altered_tumor_susceptibility | 1.26737826 |
| 51 | MP0002009_preneoplasia | 1.26396012 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.22724339 |
| 53 | MP0001873_stomach_inflammation | 1.22582888 |
| 54 | MP0009764_decreased_sensitivity_to | 1.22552171 |
| 55 | MP0000858_altered_metastatic_potential | 1.22058168 |
| 56 | MP0001986_abnormal_taste_sensitivity | 1.20487763 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.20008181 |
| 58 | MP0004883_abnormal_blood_vessel | 1.14707318 |
| 59 | MP0008004_abnormal_stomach_pH | 1.14075208 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.13887659 |
| 61 | MP0005310_abnormal_salivary_gland | 1.10994818 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.08834040 |
| 63 | MP0005451_abnormal_body_composition | 1.07469799 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 1.03399997 |
| 65 | MP0003690_abnormal_glial_cell | 0.94116585 |
| 66 | MP0004510_myositis | 0.91107789 |
| 67 | MP0001663_abnormal_digestive_system | 0.91100902 |
| 68 | MP0003075_altered_response_to | 0.89305496 |
| 69 | MP0000490_abnormal_crypts_of | 0.88186800 |
| 70 | MP0005166_decreased_susceptibility_to | 0.87699357 |
| 71 | MP0001853_heart_inflammation | 0.86559544 |
| 72 | MP0002933_joint_inflammation | 0.84920711 |
| 73 | MP0009763_increased_sensitivity_to | 0.84903470 |
| 74 | MP0000015_abnormal_ear_pigmentation | 0.81839993 |
| 75 | MP0005164_abnormal_response_to | 0.81543325 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.81081597 |
| 77 | MP0005390_skeleton_phenotype | 0.79096048 |
| 78 | MP0004130_abnormal_muscle_cell | 0.78602234 |
| 79 | MP0002006_tumorigenesis | 0.70877112 |
| 80 | MP0003448_altered_tumor_morphology | 0.70629710 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.70566906 |
| 82 | MP0005083_abnormal_biliary_tract | 0.69192944 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.68111224 |
| 84 | MP0000249_abnormal_blood_vessel | 0.67323555 |
| 85 | MP0000343_altered_response_to | 0.67166222 |
| 86 | MP0003795_abnormal_bone_structure | 0.64246053 |
| 87 | MP0000604_amyloidosis | 0.59307067 |
| 88 | MP0003045_fibrosis | 0.57851788 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.57713967 |
| 90 | MP0008874_decreased_physiological_sensi | 0.56107361 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.53826444 |
| 92 | MP0002928_abnormal_bile_duct | 0.52238782 |
| 93 | MP0004484_altered_response_of | 0.49912458 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.47596844 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.47501218 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.46842356 |
| 97 | MP0005535_abnormal_body_temperature | 0.46279426 |
| 98 | MP0008873_increased_physiological_sensi | 0.44346404 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.44292549 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.44230898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.38380265 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.65934031 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.57450028 |
| 4 | Myositis (HP:0100614) | 5.34241224 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.01273076 |
| 6 | Prolonged bleeding time (HP:0003010) | 4.89729925 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.75877960 |
| 8 | Stomatitis (HP:0010280) | 4.61728309 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.48053728 |
| 10 | Orchitis (HP:0100796) | 4.43214515 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.39298683 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.29902975 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 4.25806043 |
| 14 | Optic neuritis (HP:0100653) | 4.25806043 |
| 15 | Obstructive lung disease (HP:0006536) | 4.12778854 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 4.12778854 |
| 17 | Meningitis (HP:0001287) | 4.04008423 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 4.03122499 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.99816498 |
| 20 | Spontaneous hematomas (HP:0007420) | 3.90137154 |
| 21 | Encephalitis (HP:0002383) | 3.87867118 |
| 22 | Recurrent skin infections (HP:0001581) | 3.87272310 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.82423718 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.82423718 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.71958653 |
| 26 | Epistaxis (HP:0000421) | 3.70947292 |
| 27 | Increased IgE level (HP:0003212) | 3.49972219 |
| 28 | Pustule (HP:0200039) | 3.49192630 |
| 29 | Hypochromic microcytic anemia (HP:0004840) | 3.47943443 |
| 30 | T lymphocytopenia (HP:0005403) | 3.45379496 |
| 31 | Gingival bleeding (HP:0000225) | 3.44920758 |
| 32 | Recurrent viral infections (HP:0004429) | 3.33237308 |
| 33 | Vasculitis (HP:0002633) | 3.32735279 |
| 34 | Petechiae (HP:0000967) | 3.31878054 |
| 35 | Chest pain (HP:0100749) | 3.29598651 |
| 36 | Abnormality of T cell number (HP:0011839) | 3.29442868 |
| 37 | Inflammation of the large intestine (HP:0002037) | 3.24495754 |
| 38 | Gastrointestinal inflammation (HP:0004386) | 3.18272157 |
| 39 | Urticaria (HP:0001025) | 3.16676310 |
| 40 | Hypochromic anemia (HP:0001931) | 3.13217252 |
| 41 | Gingivitis (HP:0000230) | 3.11606574 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 3.11514641 |
| 43 | Cellulitis (HP:0100658) | 3.07898250 |
| 44 | Abnormality of T cells (HP:0002843) | 3.05126646 |
| 45 | Leukocytosis (HP:0001974) | 3.03126615 |
| 46 | Granulocytopenia (HP:0001913) | 2.98056409 |
| 47 | Agammaglobulinemia (HP:0004432) | 2.93769156 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.87302592 |
| 49 | Abnormal platelet volume (HP:0011876) | 2.84440094 |
| 50 | Purpura (HP:0000979) | 2.75362182 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.73435488 |
| 52 | Arterial thrombosis (HP:0004420) | 2.71394302 |
| 53 | Colitis (HP:0002583) | 2.70925186 |
| 54 | Hemoptysis (HP:0002105) | 2.70327348 |
| 55 | Episodic fever (HP:0001954) | 2.70318335 |
| 56 | Abnormality of T cell physiology (HP:0011840) | 2.62352157 |
| 57 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.60851286 |
| 58 | Increased IgM level (HP:0003496) | 2.59431667 |
| 59 | Pulmonary embolism (HP:0002204) | 2.58336405 |
| 60 | Microcytic anemia (HP:0001935) | 2.58251746 |
| 61 | Anorexia (HP:0002039) | 2.47690813 |
| 62 | Osteomyelitis (HP:0002754) | 2.44902892 |
| 63 | Autoimmune hemolytic anemia (HP:0001890) | 2.35888191 |
| 64 | Papilledema (HP:0001085) | 2.34282451 |
| 65 | Lymphopenia (HP:0001888) | 2.33872710 |
| 66 | Eosinophilia (HP:0001880) | 2.33531850 |
| 67 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.30644026 |
| 68 | Viral hepatitis (HP:0006562) | 2.29855002 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.26121345 |
| 70 | Sepsis (HP:0100806) | 2.23540043 |
| 71 | Menorrhagia (HP:0000132) | 2.20321482 |
| 72 | Amyloidosis (HP:0011034) | 2.20231293 |
| 73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.18552971 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 2.17088730 |
| 75 | Peritonitis (HP:0002586) | 2.15556632 |
| 76 | Papilloma (HP:0012740) | 2.14776674 |
| 77 | Verrucae (HP:0200043) | 2.14776674 |
| 78 | Increased serum ferritin (HP:0003281) | 2.13391211 |
| 79 | IgM deficiency (HP:0002850) | 2.12972447 |
| 80 | Thrombocytosis (HP:0001894) | 2.11900232 |
| 81 | Chronic otitis media (HP:0000389) | 2.09622650 |
| 82 | Skin ulcer (HP:0200042) | 2.06715577 |
| 83 | Acute hepatic failure (HP:0006554) | 2.05918566 |
| 84 | Increased mean platelet volume (HP:0011877) | 2.04855894 |
| 85 | Hepatosplenomegaly (HP:0001433) | 2.02738668 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.02307984 |
| 87 | Slow saccadic eye movements (HP:0000514) | 2.02288158 |
| 88 | Joint swelling (HP:0001386) | 2.02274791 |
| 89 | Vertigo (HP:0002321) | 2.00682523 |
| 90 | Abnormality of eosinophils (HP:0001879) | 1.99886575 |
| 91 | Autoimmune thrombocytopenia (HP:0001973) | 1.99626672 |
| 92 | Gangrene (HP:0100758) | 1.96286308 |
| 93 | Severe combined immunodeficiency (HP:0004430) | 1.96241043 |
| 94 | Abnormal platelet function (HP:0011869) | 1.94512375 |
| 95 | Impaired platelet aggregation (HP:0003540) | 1.94512375 |
| 96 | Glomerulopathy (HP:0100820) | 1.93626424 |
| 97 | Abnormality of the fingertips (HP:0001211) | 1.93584986 |
| 98 | Polycythemia (HP:0001901) | 1.91227406 |
| 99 | Amaurosis fugax (HP:0100576) | 1.89471600 |
| 100 | Increased cerebral lipofuscin (HP:0011813) | 1.89356679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.60164345 |
| 2 | MAP4K1 | 4.21038918 |
| 3 | PRPF4B | 2.98352133 |
| 4 | FES | 2.97518052 |
| 5 | BLK | 2.97374383 |
| 6 | MAP2K3 | 2.82840252 |
| 7 | TYK2 | 2.55340849 |
| 8 | GRK6 | 2.47985386 |
| 9 | TNK2 | 2.44776661 |
| 10 | ZAP70 | 2.39975969 |
| 11 | IRAK4 | 2.36354937 |
| 12 | CSK | 2.33045116 |
| 13 | BTK | 2.24385206 |
| 14 | TXK | 2.22266256 |
| 15 | ERN1 | 2.02675184 |
| 16 | SYK | 2.01630104 |
| 17 | JAK3 | 1.91775212 |
| 18 | HCK | 1.81354082 |
| 19 | MAP3K13 | 1.76788093 |
| 20 | TAOK3 | 1.72858125 |
| 21 | TEC | 1.68692465 |
| 22 | KIT | 1.60269571 |
| 23 | IKBKE | 1.56244099 |
| 24 | ITK | 1.54900703 |
| 25 | MAP3K14 | 1.53660179 |
| 26 | MAP3K3 | 1.52581907 |
| 27 | CSF1R | 1.50582900 |
| 28 | TAOK1 | 1.47665675 |
| 29 | LYN | 1.45333195 |
| 30 | TBK1 | 1.44473054 |
| 31 | FGR | 1.40454416 |
| 32 | EPHB1 | 1.39129005 |
| 33 | LCK | 1.36761352 |
| 34 | JAK1 | 1.35131344 |
| 35 | SIK3 | 1.35095440 |
| 36 | MAP3K11 | 1.33750414 |
| 37 | JAK2 | 1.25085354 |
| 38 | MARK3 | 1.21232557 |
| 39 | MAP3K1 | 1.08702100 |
| 40 | TESK2 | 1.00246881 |
| 41 | MARK2 | 0.97747857 |
| 42 | IKBKB | 0.95063347 |
| 43 | BMPR2 | 0.93660580 |
| 44 | YES1 | 0.92668187 |
| 45 | TRIB3 | 0.92460177 |
| 46 | SIK2 | 0.90532190 |
| 47 | STK10 | 0.89931188 |
| 48 | PDK1 | 0.89375790 |
| 49 | CDK19 | 0.86712240 |
| 50 | MAP3K7 | 0.86263365 |
| 51 | MAPK12 | 0.86242616 |
| 52 | PRKD2 | 0.81452053 |
| 53 | KSR2 | 0.81250337 |
| 54 | MAPK7 | 0.78639026 |
| 55 | PRKCQ | 0.78212619 |
| 56 | TAOK2 | 0.76447104 |
| 57 | HIPK2 | 0.75979708 |
| 58 | MATK | 0.74621996 |
| 59 | PTK6 | 0.69168272 |
| 60 | IRAK1 | 0.67502805 |
| 61 | PDPK1 | 0.66709892 |
| 62 | FYN | 0.65321445 |
| 63 | PTK2B | 0.64240238 |
| 64 | MAP3K6 | 0.64024808 |
| 65 | PIK3CG | 0.63666573 |
| 66 | PIM1 | 0.63624122 |
| 67 | LRRK2 | 0.62317322 |
| 68 | FGFR3 | 0.61474366 |
| 69 | IRAK2 | 0.61114253 |
| 70 | CDC42BPA | 0.59369055 |
| 71 | SMG1 | 0.58967327 |
| 72 | CDK4 | 0.56564597 |
| 73 | MAP3K10 | 0.54496687 |
| 74 | NLK | 0.54099117 |
| 75 | RPS6KL1 | 0.53613080 |
| 76 | RPS6KC1 | 0.53613080 |
| 77 | DYRK1B | 0.53547652 |
| 78 | CDK6 | 0.49110576 |
| 79 | STK11 | 0.49003261 |
| 80 | TGFBR2 | 0.48374557 |
| 81 | CAMKK1 | 0.46502698 |
| 82 | SGK3 | 0.45264030 |
| 83 | RPS6KA6 | 0.45140620 |
| 84 | MAP3K5 | 0.44626755 |
| 85 | RET | 0.43484445 |
| 86 | CAMKK2 | 0.40677364 |
| 87 | BMX | 0.40374546 |
| 88 | SIK1 | 0.35940755 |
| 89 | TTN | 0.35675077 |
| 90 | PASK | 0.33883300 |
| 91 | STK38 | 0.33702667 |
| 92 | MAP2K2 | 0.31845951 |
| 93 | MAPKAPK2 | 0.31192727 |
| 94 | SGK2 | 0.30573033 |
| 95 | CDK12 | 0.29651853 |
| 96 | MAP2K4 | 0.28655757 |
| 97 | RAF1 | 0.27851132 |
| 98 | PRKCH | 0.27637276 |
| 99 | MAP3K2 | 0.27330048 |
| 100 | PRKD1 | 0.26662472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85923527 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.71912462 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.67121805 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.62765487 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.52758050 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.44168826 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.40726711 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.39122460 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.36241146 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.98525631 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.94861762 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.92995465 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.91365262 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.89545043 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.86033749 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.84334639 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.80055967 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.78831548 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.78569776 |
| 20 | Platelet activation_Homo sapiens_hsa04611 | 1.73955638 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73009221 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.72410092 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.72271565 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.64286104 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.63775287 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.55599282 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52050765 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.52018854 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.48405672 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44573113 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42559122 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42306697 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.39191192 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35791496 |
| 35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.33147335 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24455757 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.23227715 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23079051 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.17143633 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.12340554 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11919757 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.08579294 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07023760 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06746315 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06472275 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93374011 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.90887174 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.88272141 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87736532 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87411480 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86426984 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84885158 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83784480 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.83661601 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.82435515 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79828815 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79749643 |
| 58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78771461 |
| 59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78670770 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77292204 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75630289 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73875422 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.71921665 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70798381 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70017720 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69549856 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.69062744 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67579633 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67278270 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66582170 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66559928 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66204721 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65322656 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65253607 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65228598 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65016357 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64654387 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63831017 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61068109 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60867646 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60732862 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60255485 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59614221 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59489943 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59395846 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.58262377 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57160002 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51554765 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50291769 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.49571081 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.49458080 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48737285 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42218752 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41114946 |
| 95 | Long-term potentiation_Homo sapiens_hsa04720 | 0.40677665 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36167339 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35333229 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34529807 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34318461 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33824219 |

